October 12, 2015
Johnson & Johnson starts preventive Ebola vaccine trial in Sierra Leone
Johnson & Johnson has started a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.